KL

Kun Liu

Merck: 5 patents #67 of 1,208Top 6%
LY Lycera: 3 patents #6 of 26Top 25%
AT Alectos Therapeutics: 2 patents #11 of 17Top 65%
Overall (2017): #28,754 of 506,227Top 6%
5
Patents 2017

Issued Patents 2017

Patent #TitleCo-InventorsDate
9809561 Tetrahydronaphthyridine, benzoxazine, aza-benzoxazine and related bicyclic compounds for inhibition of RORgamma activity and the treatment of disease Thomas D. Aicher, Chad A. VanHuis, William D. Thomas, John MacLean, Brian M. Andresen +9 more 2017-11-07
9783511 Carbamate benzoxazine propionic acids and acid derivatives for modulation of RORgamma activity and the treatment of disease Thomas D. Aicher, Chad A. VanHuis, John MacLean, Brian M. Andresen, Kenneth J. Barr +6 more 2017-10-10
9718854 Selective glycosidase inhibitors and uses thereof Ramesh Kaul, Ernest J. McEachern, David J. Vocadlo, Yuanxi Zhou, Harold G. Selnick +4 more 2017-08-01
9663502 2-Acylamidomethyl and sulfonylamidomethyl benzoxazine carbamates for inhibition of RORgamma activity and the treatment of disease Thomas D. Aicher, Chad A. VanHuis, John MacLean, Brian M. Andresen, Kenneth J. Barr +9 more 2017-05-30
9611275 Permeable glycosidase inhibitors and uses thereof Harold G. Selnick, Wenping Li, Eric Hostetler, Ernest J. McEachern, Yuanxi Zhou +4 more 2017-04-04